BJMO - volume 6, issue 1, february 2012
A. Stoyianni MD, PhD, G. Pentheroudakis MD, PhD, N. Pavlidis MD, PhD
Epithelial-mesenchymal transitions (EMT) occur as key steps during embryonic morphogenesis and are now implicated in the progression of primary tumours towards metastases, but also towards the accumulation of stem-cell properties. Recent advances have fostered a more detailed understanding of molecular mechanisms and networks governing EMT and leading to more dedifferentiated and malignant states. Owing to the clinical importance of the EMT-induced processes, inhibition of EMT is an attractive therapeutic approach that could have significant effect on disease outcome.
(BELG J MED ONCOL 2012;6:3–12)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
